1. Home
  2. List
  3. Detail

Reference - Detail

RRC ID 65063
Author Kikuchi A, Suzuki T, Nakazawa T, Iizuka M, Nakayama A, Ozawa T, Kameda M, Shindoh N, Terasaka T, Hirano M, Kuromitsu S.
Title ASP5878, a selective FGFR inhibitor, to treat FGFR3-dependent urothelial cancer with or without chemoresistance.
Journal Cancer Sci
Volume 108(2)
Pages 236-242
Published 2017-2-1
DOI 10.1111/cas.13124
PMID 27885740
PMC PMC5329164
MeSH ATP Binding Cassette Transporter, Subfamily B / metabolism Antineoplastic Agents / pharmacology Body Weight / drug effects Cell Line, Tumor Cell Proliferation / drug effects DNA-Binding Proteins / metabolism Deoxycytidine / analogs & derivatives Deoxycytidine / pharmacology Doxorubicin / pharmacology Drug Resistance, Neoplasm / drug effects Drug Resistance, Neoplasm / genetics Gemcitabine Gene Fusion Humans Molecular Targeted Therapy* Point Mutation Pyrazoles / pharmacology* Pyrimidines / pharmacology* Receptor, Fibroblast Growth Factor, Type 3 / antagonists & inhibitors Receptor, Fibroblast Growth Factor, Type 3 / genetics* Transcription Factors / metabolism Urologic Neoplasms / drug therapy* Urologic Neoplasms / genetics Urologic Neoplasms / metabolism
IF 4.966
Resource
Human and Animal Cells BOY-12E(RCB2627) JMSU1(RCB2227)